CN118105322A - Toothpaste with antibacterial and hemostatic functions and preparation method thereof - Google Patents
Toothpaste with antibacterial and hemostatic functions and preparation method thereof Download PDFInfo
- Publication number
- CN118105322A CN118105322A CN202410271506.XA CN202410271506A CN118105322A CN 118105322 A CN118105322 A CN 118105322A CN 202410271506 A CN202410271506 A CN 202410271506A CN 118105322 A CN118105322 A CN 118105322A
- Authority
- CN
- China
- Prior art keywords
- extract
- toothpaste
- antibacterial
- fermentation
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000606 toothpaste Substances 0.000 title claims abstract description 82
- 229940034610 toothpaste Drugs 0.000 title claims abstract description 78
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 47
- 230000002439 hemostatic effect Effects 0.000 title claims abstract description 40
- 230000006870 function Effects 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- 239000000284 extract Substances 0.000 claims abstract description 158
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 39
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 claims abstract description 33
- 244000064816 Brassica oleracea var. acephala Species 0.000 claims abstract description 33
- 235000004347 Perilla Nutrition 0.000 claims abstract description 24
- 239000000080 wetting agent Substances 0.000 claims abstract description 18
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 14
- 235000015489 Emblica officinalis Nutrition 0.000 claims abstract description 13
- 241001646828 Platostoma chinense Species 0.000 claims abstract description 13
- 244000272459 Silybum marianum Species 0.000 claims abstract description 13
- 235000010841 Silybum marianum Nutrition 0.000 claims abstract description 13
- 244000277583 Terminalia catappa Species 0.000 claims abstract description 13
- 235000011517 Terminalia chebula Nutrition 0.000 claims abstract description 13
- 235000002566 Capsicum Nutrition 0.000 claims abstract description 12
- 239000006002 Pepper Substances 0.000 claims abstract description 12
- 235000016761 Piper aduncum Nutrition 0.000 claims abstract description 12
- 235000017804 Piper guineense Nutrition 0.000 claims abstract description 12
- 235000008184 Piper nigrum Nutrition 0.000 claims abstract description 12
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims abstract description 11
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000004088 foaming agent Substances 0.000 claims abstract description 11
- 229940041616 menthol Drugs 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 11
- WSELJKAMVUHMJP-PUZYILPLSA-N (2s,3r,4s,5r)-2,3-dichloro-2,3,4,5,6-pentahydroxyhexanoyl chloride Chemical compound OC[C@@H](O)[C@H](O)[C@@](O)(Cl)[C@](O)(Cl)C(Cl)=O WSELJKAMVUHMJP-PUZYILPLSA-N 0.000 claims abstract description 8
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims abstract description 8
- 235000008702 Ilex rotunda Nutrition 0.000 claims abstract description 8
- 241000519740 Ilex rotunda Species 0.000 claims abstract description 8
- 235000010241 potassium sorbate Nutrition 0.000 claims abstract description 8
- 239000004302 potassium sorbate Substances 0.000 claims abstract description 8
- 229940069338 potassium sorbate Drugs 0.000 claims abstract description 8
- YRWWOAFMPXPHEJ-OFBPEYICSA-K sodium L-ascorbic acid 2-phosphate Chemical compound [Na+].[Na+].[Na+].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1[O-] YRWWOAFMPXPHEJ-OFBPEYICSA-K 0.000 claims abstract description 8
- 229940048058 sodium ascorbyl phosphate Drugs 0.000 claims abstract description 8
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 claims abstract description 7
- 244000124853 Perilla frutescens Species 0.000 claims abstract 4
- 244000203593 Piper nigrum Species 0.000 claims abstract 3
- 238000000855 fermentation Methods 0.000 claims description 58
- 230000004151 fermentation Effects 0.000 claims description 58
- 239000000047 product Substances 0.000 claims description 34
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 25
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 24
- 239000007788 liquid Substances 0.000 claims description 24
- 239000006228 supernatant Substances 0.000 claims description 15
- 238000003756 stirring Methods 0.000 claims description 14
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 12
- 239000004365 Protease Substances 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 11
- 108090000790 Enzymes Proteins 0.000 claims description 10
- 102000004190 Enzymes Human genes 0.000 claims description 10
- 229940088598 enzyme Drugs 0.000 claims description 10
- 238000000605 extraction Methods 0.000 claims description 10
- 235000011187 glycerol Nutrition 0.000 claims description 9
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 8
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 8
- 238000002791 soaking Methods 0.000 claims description 8
- 239000000600 sorbitol Substances 0.000 claims description 8
- 230000009471 action Effects 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 6
- 238000010564 aerobic fermentation Methods 0.000 claims description 6
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 6
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 6
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 6
- 239000008103 glucose Substances 0.000 claims description 6
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 6
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 6
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 6
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 6
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 claims description 6
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims description 6
- 239000002244 precipitate Substances 0.000 claims description 6
- 230000002829 reductive effect Effects 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- 241000193744 Bacillus amyloliquefaciens Species 0.000 claims description 5
- 241001328122 Bacillus clausii Species 0.000 claims description 5
- 241001328127 Bacillus pseudofirmus Species 0.000 claims description 5
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 5
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 5
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 239000002562 thickening agent Substances 0.000 claims description 5
- 108010004032 Bromelains Proteins 0.000 claims description 4
- 108090000270 Ficain Proteins 0.000 claims description 4
- 235000003365 Ilex pubescens Nutrition 0.000 claims description 4
- 241001100932 Ilex pubescens Species 0.000 claims description 4
- 241001647788 Nonomuraea Species 0.000 claims description 4
- 108090000526 Papain Proteins 0.000 claims description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 4
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 4
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 4
- 235000019835 bromelain Nutrition 0.000 claims description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 4
- 235000019836 ficin Nutrition 0.000 claims description 4
- POTUGHMKJGOKRI-UHFFFAOYSA-N ficin Chemical compound FI=CI=N POTUGHMKJGOKRI-UHFFFAOYSA-N 0.000 claims description 4
- 229940055729 papain Drugs 0.000 claims description 4
- 235000019834 papain Nutrition 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 4
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 239000000230 xanthan gum Substances 0.000 claims description 4
- 229920001285 xanthan gum Polymers 0.000 claims description 4
- 235000010493 xanthan gum Nutrition 0.000 claims description 4
- 229940082509 xanthan gum Drugs 0.000 claims description 4
- LRCFXGAMWKDGLA-UHFFFAOYSA-N dioxosilane;hydrate Chemical compound O.O=[Si]=O LRCFXGAMWKDGLA-UHFFFAOYSA-N 0.000 claims description 3
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims description 3
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 108700004121 sarkosyl Proteins 0.000 claims description 3
- 229960004029 silicic acid Drugs 0.000 claims description 3
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical group [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 claims description 3
- 229940045885 sodium lauroyl sarcosinate Drugs 0.000 claims description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000003906 humectant Substances 0.000 claims description 2
- 238000004140 cleaning Methods 0.000 abstract description 4
- 241000229722 Perilla <angiosperm> Species 0.000 description 20
- 239000000523 sample Substances 0.000 description 18
- 230000000052 comparative effect Effects 0.000 description 14
- 238000012360 testing method Methods 0.000 description 13
- 239000004480 active ingredient Substances 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 239000000419 plant extract Substances 0.000 description 11
- 241000722363 Piper Species 0.000 description 9
- 241000605862 Porphyromonas gingivalis Species 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 8
- 208000032843 Hemorrhage Diseases 0.000 description 7
- 208000027418 Wounds and injury Diseases 0.000 description 7
- 230000000740 bleeding effect Effects 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- SFAYBQDGCKZKMH-UHFFFAOYSA-N BNCC Chemical compound BNCC SFAYBQDGCKZKMH-UHFFFAOYSA-N 0.000 description 6
- 206010052428 Wound Diseases 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 210000000214 mouth Anatomy 0.000 description 6
- 239000006072 paste Substances 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 235000007650 Aralia spinosa Nutrition 0.000 description 3
- 208000002064 Dental Plaque Diseases 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 241000194017 Streptococcus Species 0.000 description 3
- 241000949456 Zanthoxylum Species 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000009422 growth inhibiting effect Effects 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000011587 new zealand white rabbit Methods 0.000 description 3
- 241000194108 Bacillus licheniformis Species 0.000 description 2
- 241000194103 Bacillus pumilus Species 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 241000605986 Fusobacterium nucleatum Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 2
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 2
- 241000194019 Streptococcus mutans Species 0.000 description 2
- FBUBVLUPUDBFME-UHFFFAOYSA-N Xanthoxylin Chemical group COC1=CC(O)=C(C(C)=O)C(OC)=C1 FBUBVLUPUDBFME-UHFFFAOYSA-N 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- 230000017066 negative regulation of growth Effects 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 238000009827 uniform distribution Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 229940090898 Desensitizer Drugs 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 206010018276 Gingival bleeding Diseases 0.000 description 1
- 241000209035 Ilex Species 0.000 description 1
- 235000003332 Ilex aquifolium Nutrition 0.000 description 1
- 235000002296 Ilex sandwicensis Nutrition 0.000 description 1
- 235000002294 Ilex volkensiana Nutrition 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 241000193985 Streptococcus agalactiae Species 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 206010044029 Tooth deposit Diseases 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- LFVVNPBBFUSSHL-UHFFFAOYSA-N alexidine Chemical compound CCCCC(CC)CNC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NCC(CC)CCCC LFVVNPBBFUSSHL-UHFFFAOYSA-N 0.000 description 1
- 229950010221 alexidine Drugs 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical group 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 239000007621 bhi medium Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 239000006161 blood agar Substances 0.000 description 1
- 239000008376 breath freshener Substances 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000004075 cariostatic agent Substances 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 238000011278 co-treatment Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 208000011759 gum bleeding Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 238000013168 hemostasis test Methods 0.000 description 1
- 239000002874 hemostatic agent Substances 0.000 description 1
- 238000010832 independent-sample T-test Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000009928 pasteurization Methods 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 235000010268 sodium methyl p-hydroxybenzoate Nutrition 0.000 description 1
- PESXGULMKCKJCC-UHFFFAOYSA-M sodium;4-methoxycarbonylphenolate Chemical compound [Na+].COC(=O)C1=CC=C([O-])C=C1 PESXGULMKCKJCC-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000009044 synergistic interaction Effects 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- -1 tranexamic acid) Chemical compound 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- XPFJYKARVSSRHE-UHFFFAOYSA-K trisodium;2-hydroxypropane-1,2,3-tricarboxylate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].[Na+].OC(=O)CC(O)(C(O)=O)CC(O)=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O XPFJYKARVSSRHE-UHFFFAOYSA-K 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/82—Preparation or application process involves sonication or ultrasonication
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Diabetes (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
Abstract
The invention provides toothpaste with antibacterial and hemostatic functions and a preparation method thereof, which belong to the technical field of oral cleaning products and comprise the following preparation raw materials in percentage by mass: 0.7-1.2% of collard leaf extract, 0.3-0.7% of perilla seed extract, 0.1-0.5% of pepper peel extract, 0.2-0.5% of ilex rotunda extract, 0.1-0.3% of jun-migratory fruit extract, 0.2-0.5% of silybum marianum fruit extract, 0.1-0.5% of mesona chinensis extract, 0.3-0.6% of myrobalan fruit extract, 1-4% of menthol, 20-25% of friction agent, 20-25% of wetting agent, 2-5% of foaming agent, 4-9% of tackifier, 3-7% of sodium ascorbyl phosphate, 4-8% of sodium hydroxybenzoate, 3-7% of potassium sorbate, 5-8% of trichlorogalactose, 1-2% of essence and the balance water. The toothpaste of the invention has remarkable antibacterial and hemostatic effects after being compounded by a plurality of components.
Description
Technical Field
The invention belongs to the technical field of oral cleaning products, and particularly relates to toothpaste with antibacterial and hemostatic functions and a preparation method thereof.
Background
At present, toothpaste commonly used in the market is various in types, and the functional components of the toothpaste are divided according to the functional types, and generally comprise: anticaries agent, desensitizer, antibacterial hemostatic agent, stain removing and whitening agent, dental calculus inhibitor, breath freshener, etc. The antibacterial hemostatic toothpaste is a common functional product in the market, and can inhibit the growth of oral bacteria, inhibit dental plaque, or reduce gingivitis and bleeding and repair the functional components of oral mucosa through daily use. The effective component can be bisguanidine antibacterial agent (such as chlorhexidine), quaternary amine antibacterial agent (such as cetylpyridinium chloride), triclosan, allantoin, organic acid (such as tranexamic acid), phenolic antibacterial agent (such as eugenol, thymol, paeonol), plant extract, fluoride, etc. Plant extracts are increasingly favored by consumers as hemostatic and antibacterial active ingredients.
The Chinese patent publication No. CN117503672A discloses a natural herbal formula toothpaste with antibacterial effect, the main classification No. A61K8/00, and the toothpaste has the advantages of good antibacterial effect and the like by compounding various traditional Chinese medicine components, solves the problems that the existing toothpaste lacks antibacterial components, can not effectively inhibit the growth of bacteria in the oral cavity and can not inhibit the formation of dental plaque in the use process, and has poor inhibition effect on the bacteria; chinese patent publication No. CN117462471A discloses a multifunctional toothpaste with healthy components and a preparation method thereof, the main classification No. A61K8/00, and the prepared multifunctional toothpaste has scientific formula of healthy components, can resist bacteria and diminish inflammation, and can inhibit dental plaque and decayed tooth for a long time. However, the prior art still cannot fully meet the market demand, the antibacterial and hemostatic effects of active ingredients in the toothpaste with antibacterial and hemostatic functions of the plant extracts in the market are not ideal, the storability is poor, and the compatibility stability of the plant extracts in the toothpaste in the market and toothpaste matrixes is poor, so that quality problems such as water diversion, taste change and the like of the toothpaste occur in a short time, and the efficacy is seriously reduced or even fails.
Disclosure of Invention
The invention aims to provide toothpaste with antibacterial and hemostatic functions and a preparation method thereof, and the toothpaste has remarkable antibacterial and hemostatic effects and good stability, and does not change color, split water and become smell after long-time placement by adding the plant extract into the toothpaste.
In order to achieve the above object, the present invention provides the following technical solutions:
A toothpaste with antibacterial and hemostatic functions comprises the following preparation raw materials in percentage by mass: 0.7-1.2% of collard leaf extract, 0.3-0.7% of perilla seed extract, 0.1-0.5% of pepper peel extract, 0.2-0.5% of ilex rotunda extract, 0.1-0.3% of jun-migratory fruit extract, 0.2-0.5% of silybum marianum fruit extract, 0.1-0.5% of mesona chinensis extract, 0.3-0.6% of myrobalan fruit extract, 1-4% of menthol, 20-25% of friction agent, 20-25% of wetting agent, 2-5% of foaming agent, 4-9% of tackifier, 3-7% of sodium ascorbyl phosphate, 4-8% of sodium hydroxybenzoate, 3-7% of potassium sorbate, 5-8% of trichlorogalactose, 1-2% of essence and the balance water; wherein the pepper peel extract, the pubescent holly root extract, the jun migo fruit extract, the silybum marianum fruit extract, the mesona chinensis extract and the myrobalan fruit extract are prepared into a fermentation product A in advance, and then the fermentation product A is prepared by feeding materials; the collard leaf extract and the perilla seed extract are prepared into a fermentation product B in advance, and then the fermentation product B is fed into the toothpaste.
Further, the preparation method of the collard leaf extract comprises the following steps: (1) Soaking collard leaf in 3-5 times of water for 1-2 hr, distilling for 1-2 hr, and collecting liquid and solid substances respectively; (2) Soaking the solid in 6-8 times of water for 1-2 hr, reflux extracting for 2-3 times, reflux extracting for 0.5-1 hr each time, and collecting extractive solution; (3) Concentrating the liquid and the extractive solution at 60deg.C under reduced pressure to obtain collard leaf extract.
Further, the preparation method of the perilla seed extract comprises the following steps: superfine pulverizing fructus Perillae, selecting 5-20 μm powder, adding 6-7 times of water and 10-13wt% biological enzyme, performing enzymolysis at 40-45deg.C for 1-2 hr, centrifuging to obtain supernatant 1 and precipitate, adding the precipitate into 5-6 times of extractive solution composed of 35 deg.C water and ethanol at volume ratio of 1:1, adjusting pH to 4 with citric acid-sodium citrate buffer solution, extracting in an ultrasonic device, centrifuging to obtain supernatant 2, mixing supernatant 1 and supernatant 2, and drying to obtain fructus Perillae extract.
Mixing pericarpium Zanthoxyli extract, radix Ilicis Pubescentis extract, fructus Juglandis extract, herba Silybi Mariani extract, herba mesonae chinensis extract and fructus Chebulae extract, adding into fermentation broth A of 5-7 times mass, and performing aerobic fermentation at 32deg.C for 20-25 hr, wherein the fermentation broth A comprises the following components (by mass percent): glucose 1.5%, ammonium sulfate 0.1%, monopotassium phosphate 0.04%, magnesium sulfate 0.011% and water in balance; inoculating bacillus clausii, bacillus pseudofirmus and bacillus amyloliquefaciens with the mass ratio of 1:1-3:4-6, wherein the volume percentage of the inoculated bacillus clausii, the bacillus pseudofirmus and the bacillus amyloliquefaciens in the fermentation liquid A is 2.5%, and drying at 60 ℃ after the fermentation is finished to obtain a fermentation product A.
Mixing collard leaf extract and fructus Perillae extract, adding into fermentation liquid B5-7 times of the mass, and performing aerobic fermentation at 35deg.C for 25-30 hr, wherein the fermentation liquid B comprises the following components by mass percent: glucose 1%, ammonium sulfate 0.1%, monopotassium phosphate 0.05%, magnesium sulfate 0.012% and water in balance; and inoculating 3% of saccharomyces cerevisiae BY4742, nonomuria and Ji Shiku termates in the mass ratio of 0.1-0.5:2-4:1 in the fermentation liquid B, and drying at 60 ℃ after the compound fermentation is finished to obtain a fermentation product B.
Further, bacillus clausii accession no: BNCC191581; bacillus pseudofirmus accession No.: BNCC186420; bacillus amyloliquefaciens accession No.: BNCC336388; saccharomyces cerevisiae BY4742, accession number: BNCC342164. Nonomuria and accession number: BNCC276654; ji Shiku termyces, accession number: BNCC232040. All the strains are purchased from Beijing Beidou Nachuang biological technology institute.
The invention prepares the collard leaves by distillation and then extraction, simultaneously, in the treatment of the perilla seeds, superfine grinding is firstly carried out, which is beneficial to the enzymolysis of subsequent biological enzymes. The invention combines the extracts obtained by a specific method of the collard leaves and the perilla seeds to promote the synergistic interaction among the components, and uses specific strains to ferment, and the prepared fermentation product has good antibacterial and hemostatic effects when being added into the system of the invention. The commercially available two plant extracts have unstable content of active ingredients and may contain a large amount of other ingredients, and the substances have no antibacterial and hemostatic effects, but are possibly associated with the active ingredients to prevent the active ingredients from playing roles. However, other toothpaste matrices in the present system have poor compatibility with fermentation products of collard leaf extract and perilla seed extract.
Through a large number of research and development experiments, the inventor adds a plurality of plant extracts such as a pricklyash peel extract, a radix clerodendroa cyrtophylli extract, a junior fruit extract, a silybum marianum fruit extract, a mesona chinensis extract and a myrobalan fruit extract into the toothpaste, and through the addition of the extracts, the antibacterial and hemostatic functions of the toothpaste are improved by synergistic effect, and the inventor also surprisingly discovers that the compatibility of a toothpaste matrix, a collard leaf extract and a perilla seed extract is improved after the addition, so that the toothpaste is not easy to deteriorate at normal temperature, and the quality problems such as water diversion and taste change are not easy to occur. However, the stability of toothpaste at high temperatures is still not ideal.
The sources of the pepper peel extract, the ilex pubescens extract, the jun migo fruit extract, the silybum marianum fruit extract, the mesona chinensis extract and the myrobalan fruit extract are not particularly limited.
Further, the extraction conditions in the ultrasonic device are: under the action of 40Hz ultrasonic wave, the extraction temperature is 30 ℃ and the extraction time is 20-30min.
In order to improve the anti-inflammatory effect of the toothpaste, the biological enzyme comprises papain, ficin and bromelain with the mass ratio of 1-3:1:0.5-1.
Further, the wetting agent is one or more selected from sorbitol, glycerol and propylene glycol.
Further, the wetting agent is sorbitol, glycerol and propylene glycol with the mass ratio of 1:2-5:0.1-0.4.
The inventor adds a wetting agent to help dissolve other ingredients in the toothpaste, so that the ingredients are better and evenly mixed together, the uniform distribution of various active ingredients in the toothpaste is facilitated, and the consistent effect can be ensured for each use. The inventors have unexpectedly found that stability of the toothpaste at high temperatures can be improved when the humectant is sorbitol, glycerin and propylene glycol in a mass ratio of 1:2-5:0.1-0.4. It is hypothesized that the wetting agent under the conditions is favorable for maintaining the original structure and characteristics of the toothpaste, and meanwhile, a firm protective film can be formed on the surface of the active ingredient, so that the contact between the active ingredient and a high-temperature environment is reduced, and the stability of the active ingredient is improved.
Further, the friction agent is one or two selected from hydroxyapatite and hydrated silica.
Further, the tackifier is hydroxyethyl cellulose, xanthan gum and sodium carboxymethyl cellulose with the mass ratio of 2-5:1:0.5-1.
Compared with the antibacterial and hemostatic effects of chemical agents, the natural plant extract has the greatest defects that the natural plant extract is combined with the oral cavity for a short time, only about 2 minutes of tooth brushing is needed, and the active ingredients are flushed away after rinsing, so that the antibacterial and hemostatic effects are limited. In order to solve the contradiction, the inventor tries to adjust the auxiliary ingredients in the formula, and surprisingly discovers that when the tackifier is hydroxyethyl cellulose, xanthan gum and sodium carboxymethyl cellulose with the mass ratio of 2-5:1:0.5-1, the gum bleeding time can be reduced. The action mechanism of the tackifier does not uniformly improve the viscosity of paste, paste residues are not left in the oral cavity after the paste is rinsed by clean water, bacteria breeding in the oral cavity caused by the paste residues can be avoided, but the antibacterial and hemostatic effects are improved through tests, and the fact that the tackifier is used for enabling a fermentation product to be in contact with the inner wall of the oral cavity more easily after being combined is suspected, the retention time on the inner wall of the oral cavity is longer, the paste is not easy to wash away by back water, the action effect is better, and the hemostatic effect is improved.
Further, the foaming agent is selected from sodium lauroyl sarcosinate or sodium dodecyl sulfate.
Further, the pricklyash peel extract is xanthoxylin.
Further, the toothpaste comprises the following preparation raw materials in percentage by mass: 1% of collard leaf extract, 0.5% of perilla seed extract, 0.3% of pepper peel extract, 0.4% of ilex rotunda extract, 0.2% of junior fruit extract, 0.4% of silybum marianum fruit extract, 0.2% of mesona chinensis extract, 0.5% of myrobalan fruit extract, 2% of menthol, 22% of friction agent, 22% of wetting agent, 3% of foaming agent, 6% of tackifier, 5% of sodium ascorbyl phosphate, 6% of sodium hydroxybenzoate, 4% of potassium sorbate, 6% of trichlorogalactose, 1% of essence and the balance of water.
The invention also provides a preparation method of the toothpaste with the antibacterial and hemostatic functions, which comprises the following steps: dissolving fermentation product A, fermentation product B and menthol in water, adding friction agent, stirring for 10-20min, adding thickener, stirring for 5-10min, adding the rest components, stirring until no granule exists, and stirring under vacuum for 10-20min.
Further, the stirring speed is 900-1000r/min.
The raw materials of the present invention are all commercially available unless otherwise specified.
Compared with the prior art, the invention has the advantages that:
1. The invention provides toothpaste with antibacterial and hemostatic functions and a preparation method thereof, and the toothpaste has remarkable antibacterial and hemostatic effects and good stability by adding the plant extract into the toothpaste.
2. The invention distills and then extracts the collard leaves, superfine grinding is carried out on the perilla seeds, which is more beneficial to the enzymolysis of subsequent biological enzymes. The invention combines specific extracts and promotes the synergistic effect among the components, so that the system provided by the invention has good antibacterial and hemostatic effects by adding the collard leaf extract and the perilla seed extract.
3. The collard leaf extract and the perilla seed extract of the invention only use specific components, and the usage amount of the effective components is accurate and controllable, thereby improving the curative effect of bacteriostasis and hemostasis.
4. The toothpaste is added with various plant extracts including pepper peel extract, iron holly extract, jun migratory fruit extract, silybum marianum fruit extract, mesona chinensis extract and myrobalan fruit extract, so that the antibacterial and hemostatic functions of the toothpaste are improved, the compatibility of a toothpaste matrix, collard leaf extract and perilla seed extract is unexpectedly improved, and the toothpaste is not easy to deteriorate at normal temperature.
5. The wetting agent is added to help dissolve other ingredients in the toothpaste, so that the ingredients are better and evenly mixed together, the uniform distribution of various active ingredients in the toothpaste is facilitated, and the consistent effect can be ensured for each use. When the wetting agent is sorbitol, glycerol and propylene glycol with the mass ratio of 1:2-5:0.1-0.4, the stability of the toothpaste at high temperature can be improved.
Drawings
FIG. 1 is a graph showing the comparison of the inhibitory effect of sample B on Porphyromonas gingivalis growth;
FIG. 2 is a graph showing the experiment of inhibiting growth of Porphyromonas gingivalis in sample B;
FIG. 3 is a graph showing comparison of the effect of sample B on inhibition of F.nucleatum growth;
FIG. 4 is a graph showing the experiment of inhibiting the growth of F.nucleatum in sample B;
FIG. 5 is a graph showing comparison of the inhibition effect of sample B on the growth of Streptococcus mutans;
FIG. 6 is a graph of sample B showing inhibition of growth of Streptococcus mutans;
FIG. 7 is a graph showing comparison of the growth inhibitory effect of sample B on Streptococcus agalactiae;
FIG. 8 is a graph showing the experiment of inhibiting growth of Streptococcus gossypii in sample B;
FIG. 9 is a graph showing comparison of the growth inhibitory effect of sample B on Streptococcus distant;
FIG. 10 is a graph of sample B showing inhibition of growth of Streptococcus distant;
FIG. 11 is a graph showing the comparison of the growth inhibitory effect of the toothpaste prepared in example 1 and other toothpastes on Porphyromonas gingivalis;
FIG. 12 is a graph showing the experiment of the toothpaste prepared in example 1 and other toothpastes for inhibiting Porphyromonas gingivalis.
Detailed Description
The following description of the technical solutions in the embodiments of the present invention will be clear and complete, and it is obvious that the described embodiments are only some embodiments of the present invention, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
Example 1
The embodiment provides toothpaste with antibacterial and hemostatic functions, which comprises the following preparation raw materials in percentage by mass: 1% of collard leaf extract, 0.5% of perilla seed extract, 0.3% of pepper peel extract, 0.4% of ilex rotunda extract, 0.2% of junior fruit extract, 0.4% of silybum marianum fruit extract, 0.2% of mesona chinensis extract, 0.5% of myrobalan fruit extract, 2% of menthol, 22% of friction agent, 22% of wetting agent, 3% of foaming agent, 6% of tackifier, 5% of sodium ascorbyl phosphate, 6% of sodium hydroxybenzoate, 4% of potassium sorbate, 6% of trichlorogalactose, 1% of essence and the balance of water.
Preparing a fermentation product A from a pepper peel extract, a ilex pubescens extract, a monarch fruit extract, a silybum marianum fruit extract, a mesona chinensis extract and a myrobalan fruit extract in advance, and then preparing the toothpaste by feeding materials; preparing a fermentation product B from collard leaf extract and perilla seed extract in advance, and then feeding materials to prepare the toothpaste;
The preparation method of the collard leaf extract comprises the following steps: (1) Soaking collard leaves in 4 times of water for 1.5 hr, distilling for 1.5 hr, and collecting liquid and solid substances respectively; (2) Soaking the solid in 7 times of water for 1.5h, reflux-extracting for 3 times, reflux-extracting for 1h each time, and collecting extractive solution; (3) Concentrating the liquid and the extractive solution at 60deg.C under reduced pressure to obtain collard leaf extract.
The preparation method of the perilla seed extract comprises the following steps: superfine pulverizing fructus Perillae, selecting 5-20 μm powder, adding 7 times of water and 12wt% biological enzyme, performing enzymolysis at 43deg.C for 1 hr, centrifuging to obtain supernatant 1 and precipitate, adding the precipitate into 6 times of extractive solution composed of 35 deg.C water and ethanol at volume ratio of 1:1, extracting in ultrasonic device, centrifuging to obtain supernatant 2, mixing supernatant 1 and supernatant 2, and drying to obtain fructus Perillae extract.
The extraction conditions in the ultrasonic device are as follows: under the action of 40Hz ultrasonic wave, the extraction temperature is 30 ℃ and the extraction time is 25min.
The biological enzyme comprises papain, ficin and bromelain with the mass ratio of 2:1:0.7.
Mixing pericarpium Zanthoxyli extract, radix Ilicis Pubescentis extract, fructus Juglandis extract, herba Silybi Mariani extract, herba mesonae chinensis extract and fructus Chebulae extract, adding into 6 times mass of fermentation liquid A, and performing aerobic fermentation at 32deg.C for 22 hr, wherein the fermentation liquid A comprises the following components by mass percent: glucose 1.5%, ammonium sulfate 0.1%, monopotassium phosphate 0.04%, magnesium sulfate 0.011% and water in balance; inoculating bacillus clausii, bacillus pseudofirmus and bacillus amyloliquefaciens with the volume percentage of 2.5% in the fermentation liquid A, and drying at 60 ℃ after fermentation to obtain a fermentation product A;
Mixing collard leaf extract and fructus Perillae extract, adding into 6 times of fermentation liquid B, and performing aerobic fermentation at 35deg.C for 27 hr, wherein the fermentation liquid B comprises the following components by mass percent: glucose 1%, ammonium sulfate 0.1%, monopotassium phosphate 0.05%, magnesium sulfate 0.012% and water in balance; inoculating 3% of saccharomyces cerevisiae BY4742, nonomuria and Ji Shiku termates in the mass ratio of 0.3:3:1 in the fermentation liquid B, and drying at 60 ℃ after fermentation to obtain a fermentation product B.
The wetting agent is sorbitol, glycerol and propylene glycol with the mass ratio of 1:3:0.3.
The friction agent is prepared by compounding hydroxyapatite and hydrated silica according to a mass ratio of 3:1.
The tackifier is hydroxyethyl cellulose (purchased from merck, 09368), xanthan gum (purchased from merck, G1253) and sodium carboxymethyl cellulose (purchased from merck, C9481) with a mass ratio of 3:1:0.7. The foaming agent was sodium lauroyl sarcosinate (available from merck, Y0001772).
The embodiment also provides a preparation method of the toothpaste with antibacterial and hemostatic functions, which comprises the following steps: dissolving the fermentation product A, the fermentation product B and menthol in water, adding a friction agent, stirring for 15min at 950r/min, adding a thickening agent, stirring for 10min at 950r/min, continuously adding the rest components, stirring for 950r/min until no particles exist, and continuously stirring for 15min at 950r/min under vacuum.
Example 2
The differences between this embodiment and embodiment 1 are: a toothpaste with antibacterial and hemostatic functions comprises the following preparation raw materials in percentage by mass: 1.1% of collard leaf extract, 0.4% of perilla seed extract, 0.3% of pricklyash peel extract, 0.2% of ilex rotunda extract, 0.3% of Junzel fruit extract, 0.2% of silybum marianum fruit extract, 0.5% of mesona chinensis extract, 0.3% of myrobalan fruit extract, 2% of menthol, 24% of friction agent, 22% of wetting agent, 3% of foaming agent, 5% of tackifier, 4% of sodium ascorbyl phosphate, 6% of sodium hydroxybenzoate, 5% of potassium sorbate, 7% of trichlorogalactose, 1% of essence and the balance of water.
Example 3
The differences between this embodiment and embodiment 1 are: the biological enzyme comprises papain, ficin and bromelain in a mass ratio of 3:1:1. The wetting agent is sorbitol, glycerol and propylene glycol with the mass ratio of 1:5:0.2.
Comparative example 1
The difference between this comparative example and example 1 is: a toothpaste with antibacterial and hemostatic functions comprises the following preparation raw materials in percentage by mass: the composition comprises 0.4% of collard leaf extract, 1% of perilla seed extract, 0.7% of pepper peel extract, 0.1% of ilex rotunda extract, 0.5% of junior fruit extract, 0.1% of silybum marianum fruit extract, 0.2% of mesona chinensis extract, 0.3% of myrobalan fruit extract, 2% of menthol, 27% of friction agent, 23% of wetting agent, 5% of foaming agent, 3% of tackifier, 8% of sodium ascorbyl phosphate, 3% of sodium hydroxybenzoate, 5% of potassium sorbate, 7% of trichlorogalactose, 1% of essence and the balance of water.
Comparative example 2
The difference between this comparative example and example 1 is: a toothpaste with antibacterial and hemostatic functions comprises the following preparation raw materials in percentage by mass: 1% of collard leaf extract, 0.5% of perilla seed extract, 0.5% of pepper peel extract, 0.6% of ilex rotunda extract, 2% of menthol, 22% of friction agent, 22% of wetting agent, 3% of foaming agent, 6% of tackifier, 5% of sodium ascorbyl phosphate, 6% of sodium methylparaben, 4% of potassium sorbate, 6% of trichlorogalactose, 1% of essence and the balance of water.
Comparative example 3
The difference between this comparative example and example 1 is:
Inoculating bacillus subtilis (accession number: BNCC 188026), bacillus licheniformis (accession number: BNCC 336463) and bacillus pumilus (accession number: BNCC 103925) with a mass ratio of 1:1:1 in the fermentation broth A, and drying at 60 ℃ after fermentation to obtain a fermentation product A;
Inoculating bacillus subtilis (accession number: BNCC 188026), bacillus licheniformis (accession number: BNCC 336463) and bacillus pumilus (accession number: BNCC 103925) with the mass ratio of 1:1:1 in the fermentation broth B accounting for 3%, and drying at 60 ℃ after fermentation to obtain a fermentation product B.
All the strains are purchased from Beijing Beidou Nachuang biological technology institute.
Comparative example 4
The difference between this comparative example and example 1 is: the wetting agent is polyethylene glycol, glycerol and stearyl alcohol with the mass ratio of 1:1:1.
Comparative example 5
The difference between this comparative example and example 1 is: the tackifier is hydroxyethyl cellulose, carrageenan (purchased from merck, C1138) and colloidal magnesium aluminum silicate (CAS number: 71205-22-6) with the mass ratio of 1:1:1.
Performance testing
(1) Referring to GQT/ZY-DL-001, the instruction for the liver hemostasis test of rabbit,
1. Materials and methods
1. Test article toothpaste of examples 1-3 and comparative examples 1-5.
2. Experimental animals and raising environment
Common grade New Zealand white rabbits, female, weight 2.0kg ~2.5kg, by Guangdong province medical laboratory animal center (three water base) provides, laboratory animal production license number SCXK (Guangdong) 2019-0035, quality certification number No.44411600011769. Feed was provided by the medical laboratory animal center in Guangdong province. After purchasing, animals are fed in a single cage of a home animal house, and are used after quarantine is qualified, the use license number of experimental animals is SYXK (Yue) 2018-0137, the temperature of the animal house is 18-26 ℃, and the relative humidity is 40-70%.
3. Instrument and reagent
The main instrument is an electronic balance, the model number is QUINTIX3102-1CN, the stopwatch, and the model number is Tianfu brand PC70. Reagent 3% sodium pentobarbital.
4. The test method comprises the following steps:
4.1, taking 48 New Zealand white rabbits qualified in quarantine, and dividing the New Zealand white rabbits into 8 groups of 6 rabbits each.
4.2 After intravenous injection of 3% pentobarbital sodium for anesthesia, the liver was exposed by opening the abdomen layer by layer, and the wound surface of 1cm×1cm×3mm was clamped at the lower edge of the left lobe of the liver. After the wound surface is full of blood, 1.0g of the sample to be tested is coated on the whole wound surface, covered by gauze, and pressurized on the gauze by a weight of 50g, and the hemostatic effect is observed. The wounds of the model control group were not coated with the test sample, covered with gauze, and pressurized on the gauze with a 50g weight as a control. Every 30 seconds, observing bleeding of the wound, slightly dipping and sucking with a filter paper strip until the blood is no longer oozed, namely, the filter paper strip is no longer stained with blood, and recording the required time, namely, bleeding time.
4.3 Statistical analysis, experimental data are expressed in terms of standard deviation of mean soil, and SPSS software is adopted to conduct independent sample T test.
2. Test results
The test results of the local wound injury bleeding time test of the livers of the rabbits in each group are shown in the table 1 below.
Table 1: bleeding time test
As is clear from examples 1 and comparative example 5, the bleeding time becomes longer after changing the kind and the ratio of the thickener, indicating that the kind and the ratio of the specific thickener can reduce the bleeding time.
(2) Reference WS/T650-2019 methods for evaluating antibacterial and bacteriostatic effects; concentration of action the products of examples 1-3 and comparative examples 1-5 were as such and duration of action was 20min. The results of the antibacterial effect test are shown in table 2.
Table 2: antibacterial effect test
(3) The fermentation product B obtained by mixing the collard leaf extract and the perilla seed extract prepared in example 1 in a mass ratio of 2:1 was subjected to biological property test, and the results are shown in Table 3.
Table 3: testing of biological Properties
(4) Taking Porphyromonas gingivalis strains, and inoculating the Porphyromonas gingivalis strains on a blood agar plate for one-time activation. The other four strains were each subjected to activation culture on BHI plates. (2) after the cultivation is finished, the purity is determined by microscopic examination. Then respectively transferring BHI liquid culture medium for activating culture. (3) After microscopic examination is carried out to determine the purity, the BHI liquid culture medium is activated for 20 hours, transfer is carried out for secondary activation, activated culture solutions are respectively subjected to viable count, dilution factors with the concentration of the obtained bacterial suspension being 1-5 x 10 6 cfu/ml are determined, the process is repeated for three times, and a bacterial suspension concentration inoculation amount scheme is confirmed.
Sample B aqueous solution preparation: the collard leaf extract and the perilla seed extract prepared in example 1 are mixed and fermented according to a mass ratio of 2:1 to obtain a fermentation product B, the fermentation product B is taken as a sample B to be dissolved in water to prepare 20mg/mL mother liquor, and the mother liquor is respectively diluted to prepare 10mg/mL,5mg/mL, 2.5mg/mL and 1.25mg/mL sample solutions, and the mixture is subjected to pasteurization at 70 ℃ for 30 minutes for later use.
Preparing toothpaste samples: weighing 3g of toothpaste prepared in example 1, dissolving in 7ml of water to prepare 30% toothpaste liquid, sufficiently shaking, soaking for 30 minutes, and centrifuging to obtain supernatant for later use; weighing 3g of silver-cleaning toothpaste, dissolving in 7ml of water to prepare 30% toothpaste liquid, sufficiently vibrating, soaking for 30 minutes, and centrifuging to obtain a supernatant for later use; 3g of Yunnan white drug powder toothpaste is weighed and dissolved in 7ml of water to prepare 30% toothpaste liquid, the toothpaste liquid is fully vibrated, soaked for 30 minutes, and the supernatant is centrifugally taken for standby.
Five concentration gradients of 10mg/mL,5mg/mL, 2.5mg/mL, 1.25mg/mL and 0.0625mg/mL are adopted to carry out bacteriostasis experiments on Porphyromonas gingivalis, and the bacteriostasis effect is determined. 1) Experimental group samples: 100ul of sample B+100ul of bacterial suspension are respectively packaged in an orifice plate, the concentration of the sample B is respectively 10mg/ml, 0.5mg/ml, 0.25mg/ml and 0.125 mg/ml+fresh bacterial suspension are respectively packaged in experimental group orifice plates with corresponding sample concentrations, and five parallel samples are respectively used for ensuring the bacterial concentration of each orifice plate to be consistent; 2) Positive control of control sample: 100ul of physiological saline and 100ul of bacterial-containing BHI culture medium are added, and three parallel samples are arranged; negative control: 100ul sample B (corresponding concentration) +100ul of sterile BHI medium, three replicates; the experimental group and the control group are simultaneously placed in an anaerobic environment at 37 ℃ for co-treatment for 24 hours, then an enzyme-labeled instrument is used for measuring the OD600 value of the pore plate, and the result is recorded by photographing;
Determination of the concentration of bacterial suspension according to the test procedure, each strain was subjected to secondary activation under appropriate conditions for 20 hours, and the test was repeated 3 times or more to obtain an initial bacterial suspension concentration of (1 to 5) ×10 6 CFU/mL and the inoculum size thereof was as shown in table 4 below.
Table 4: inoculum size
1-12, The toothpaste prepared in example 1 has better inhibition effect on Porphyromonas gingivalis growth under the condition of multiple dilutions, and keeps consistent with the antibacterial result of the raw materials. The comparison experiment results of the toothpaste of the example 1 with the Yunnan white drug powder and the silver-cleaning toothpaste show that several toothpastes all show good growth inhibition effect, and only the toothpaste prepared in the example 1 has obvious inhibition effect on the growth of Porphyromonas gingivalis under the condition of multiple dilutions, and keeps consistent with the raw material antibacterial result.
(5) Stability test
The toothpastes prepared in examples 1 to 3 and comparative examples 1 to 5 were left at room temperature (25 ℃) and 40℃for 5 months, and the paste was observed. The results are shown in Table 5.
Table 5: stability test
As is clear from Table 5, the product of the present invention has good stability and does not deteriorate after long-term use. While the foregoing is directed to the preferred embodiments of the present invention, it will be appreciated by those skilled in the art that various modifications and adaptations can be made without departing from the principles of the present invention, and such modifications and adaptations are intended to be comprehended within the scope of the present invention.
Claims (10)
1. The toothpaste with the antibacterial and hemostatic functions is characterized by comprising the following preparation raw materials in percentage by mass: 0.7-1.2% of collard leaf extract, 0.3-0.7% of perilla seed extract, 0.1-0.5% of pepper peel extract, 0.2-0.5% of ilex rotunda extract, 0.1-0.3% of jun-migratory fruit extract, 0.2-0.5% of silybum marianum fruit extract, 0.1-0.5% of mesona chinensis extract, 0.3-0.6% of myrobalan fruit extract, 1-4% of menthol, 20-25% of friction agent, 20-25% of wetting agent, 2-5% of foaming agent, 4-9% of tackifier, 3-7% of sodium ascorbyl phosphate, 4-8% of sodium hydroxybenzoate, 3-7% of potassium sorbate, 5-8% of trichlorogalactose, 1-2% of essence and the balance water;
wherein the pepper peel extract, the pubescent holly root extract, the jun migo fruit extract, the silybum marianum fruit extract, the mesona chinensis extract and the myrobalan fruit extract are prepared into a fermentation product A in advance, and then the fermentation product A is prepared by feeding materials;
The collard leaf extract and the perilla seed extract are prepared into a fermentation product B in advance, and then the fermentation product B is fed into the toothpaste;
The preparation method of the collard leaf extract comprises the following steps: (1) Soaking collard leaf in 3-5 times of water for 1-2 hr, distilling for 1-2 hr, and collecting liquid and solid substances respectively; (2) Soaking the solid in 6-8 times of water for 1-2 hr, reflux extracting for 2-3 times, reflux extracting for 0.5-1 hr each time, and collecting extractive solution; (3) Mixing the liquid and the extract, and concentrating at 60deg.C under reduced pressure to obtain collard leaf extract;
The preparation method of the perilla seed extract comprises the following steps: superfine pulverizing fructus Perillae, selecting 5-20 μm powder, adding 6-7 times of water and 10-13% of biological enzyme by mass percentage of fructus Perillae, performing enzymolysis at 40-45deg.C for 1-2 hr, centrifuging to obtain supernatant 1 and precipitate, adding the precipitate into 5-6 times of extractive solution composed of 35 deg.C water and ethanol at volume ratio of 1:1, extracting in ultrasonic device, centrifuging to obtain supernatant 2, mixing the supernatant 1 and supernatant 2, and drying to obtain fructus Perillae extract;
mixing pericarpium Zanthoxyli extract, radix Ilicis Pubescentis extract, fructus Juglandis extract, herba Silybi Mariani extract, herba mesonae chinensis extract and fructus Chebulae extract, adding into fermentation broth A of 5-7 times mass, and performing aerobic fermentation at 32deg.C for 20-25 hr, wherein the fermentation broth A comprises the following components (by mass percent): glucose 1.5%, ammonium sulfate 0.1%, monopotassium phosphate 0.04%, magnesium sulfate 0.011% and water in balance; inoculating bacillus clausii, bacillus pseudofirmus and bacillus amyloliquefaciens with the volume percentage of 2.5% in the fermentation liquid A in a mass ratio of 1:1-3:4-6, and drying at 60 ℃ after fermentation to obtain a fermentation product A;
Mixing collard leaf extract and fructus Perillae extract, adding into fermentation liquid B5-7 times of the mass, and performing aerobic fermentation at 35deg.C for 25-30 hr, wherein the fermentation liquid B comprises the following components by mass percent: glucose 1%, ammonium sulfate 0.1%, monopotassium phosphate 0.05%, magnesium sulfate 0.012% and water in balance; inoculating Saccharomyces cerevisiae BY4742, nonomuria and Ji Shiku termates with the volume percentage of 3% in the fermentation liquid B of 0.1-0.5:2-4:1, and drying at 60 ℃ after fermentation to obtain a fermentation product B.
2. The toothpaste with antibacterial and hemostatic functions according to claim 1, wherein the extraction conditions in the ultrasonic device are: under the action of 40Hz ultrasonic wave, the extraction temperature is 30 ℃ and the extraction time is 20-30min.
3. The toothpaste with antibacterial and hemostatic functions according to claim 2, wherein the biological enzymes comprise papain, ficin and bromelain in a mass ratio of 1-3:1:0.5-1.
4. The toothpaste having antibacterial and hemostatic functions according to claim 1, wherein the humectant is one or more selected from sorbitol, glycerin, propylene glycol.
5. The toothpaste with antibacterial and hemostatic functions according to claim 4, wherein the wetting agent is sorbitol, glycerol and propylene glycol in a mass ratio of 1:2-5:0.1-0.4.
6. The toothpaste having antibacterial and hemostatic functions according to claim 1, wherein the abrasive is one or both selected from the group consisting of hydroxyapatite and hydrated silica.
7. The toothpaste with antibacterial and hemostatic functions according to claim 1, wherein the tackifier is hydroxyethyl cellulose, xanthan gum and sodium carboxymethyl cellulose with a mass ratio of 2-5:1:0.5-1.
8. The toothpaste having antibacterial and hemostatic functions according to claim 1, wherein the foaming agent is selected from sodium lauroyl sarcosinate or sodium dodecyl sulfate.
9. The method for preparing the toothpaste with antibacterial and hemostatic functions according to any one of claims 1 to 8, comprising the following steps: dissolving fermentation product A, fermentation product B and menthol in water, adding friction agent, stirring for 10-20min, adding thickener, stirring for 5-10min, adding the rest components, stirring until no granule exists, and stirring under vacuum for 10-20min.
10. The method for preparing toothpaste with antibacterial and hemostatic functions according to claim 9, wherein the stirring speed is 900-1000r/min.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410271506.XA CN118105322A (en) | 2024-03-11 | 2024-03-11 | Toothpaste with antibacterial and hemostatic functions and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410271506.XA CN118105322A (en) | 2024-03-11 | 2024-03-11 | Toothpaste with antibacterial and hemostatic functions and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN118105322A true CN118105322A (en) | 2024-05-31 |
Family
ID=91215058
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410271506.XA Pending CN118105322A (en) | 2024-03-11 | 2024-03-11 | Toothpaste with antibacterial and hemostatic functions and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN118105322A (en) |
-
2024
- 2024-03-11 CN CN202410271506.XA patent/CN118105322A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106924120A (en) | A kind of oral care substance of antibacterial, fresh breath | |
EP3552600A1 (en) | Composition containing dendrobium candidum extract and preparation method and use thereof | |
TWI750716B (en) | Topical composition and its use for preparation of composition for improving skin disease and dermatitis | |
CN110946813B (en) | Compound fermentation extract containing cubilose and preparation method and application thereof | |
CN113648274B (en) | Anti-aging composition and preparation method and application thereof | |
CN110934804A (en) | Skin micro-ecological nursing mask added with distiller's grains | |
CN114869815B (en) | Anti-dandruff antibacterial shampoo and preparation method thereof | |
CN115463048A (en) | Acne-removing face-refreshing essence and preparation method thereof | |
US20040058023A1 (en) | Skin external preparation containing pine pollen or pine pollen extract | |
CN108969455B (en) | Acne-removing and moisturizing composition containing herba violae and application of acne-removing and moisturizing composition | |
CN111529457B (en) | Tea-containing formula toothpaste capable of regulating flora and preparation method and application thereof | |
CN118105322A (en) | Toothpaste with antibacterial and hemostatic functions and preparation method thereof | |
CN111358735A (en) | Lactobacillus rice fermentation product and preparation method thereof | |
CN114869840B (en) | Prebiotic face cream and preparation method thereof | |
CN114767609A (en) | Cosmetic composition with skin activating and anti-aging effects | |
CN113384508A (en) | A toothpaste containing rice extract and its preparation method | |
CN113694006A (en) | Tooth-care toothpaste capable of effectively inhibiting dental plaque | |
CN113244140A (en) | Composition for regulating skin micro-ecological balance and application and preparation method thereof | |
FR2931675A1 (en) | Cosmetic or dermatological composition, useful e.g. for cosmetic treatment e.g. to tighten pores, and inhibit growth of Staphylococcus aureus, comprises rice extract, rice vinegar, matte powder, meadowsweet extract and essential oil | |
CN117717507B (en) | Hair-blacking and hair-loss-preventing essence containing plant extracts and preparation method thereof | |
CN117298198B (en) | Microalgae extract and application thereof | |
TWI819833B (en) | Vaginal cleaning composition | |
KR102568146B1 (en) | Composition for Anti-Bacterial, Skin Pore Reducing, and Pore Shrinkage Property Comprising Mixture of Sucrose, Trehalose, and Hyaluronic Acid as Active Ingredient | |
CN117511827B (en) | A folium Platycladi fermentation product for caring scalp, controlling oil and removing dandruff, and its preparation method and application | |
CN117338684B (en) | Fermentation liquor for nourishing hair, blackening hair and preventing alopecia and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication |